BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Facchini FA, Coelho H, Sestito SE, Delgado S, Minotti A, Andreu D, Jiménez-Barbero J, Peri F. Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid. ChemMedChem 2018;13:280-7. [PMID: 29265636 DOI: 10.1002/cmdc.201700694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Facchini FA, Coelho H, Sestito SE, Delgado S, Minotti A, Andreu D, Jiménez-Barbero J, Peri F. Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid. ChemMedChem 2018;13:280-7. [PMID: 29265636 DOI: 10.1002/cmdc.201700694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Romerio A, Peri F. Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview. Front Immunol 2020;11:1210. [PMID: 32765484 DOI: 10.3389/fimmu.2020.01210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Cochet F, Facchini FA, Zaffaroni L, Billod JM, Coelho H, Holgado A, Braun H, Beyaert R, Jerala R, Jimenez-Barbero J, Martin-Santamaria S, Peri F. Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties. Sci Rep 2019;9:919. [PMID: 30696900 DOI: 10.1038/s41598-018-37421-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]